How many clinical trials are tracked of ibudilast?

6 trials are tracked, 0 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Urology Hematology Ophthalmology Dermatology Emergency Medicine Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

ibudilast

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of ibudilast

6 trials tracked of ibudilast.

6Trials tracked

0Phase 3 & 4

0Recruiting

0With published results

Phase distribution

Phase 2 6

Phase 2 Efficacy, Safety, Tolerability, and Biomarkers of Ibudilast (MN-166) in Patients Hospitalized With COVID-19 at Risk for ARDS Completed
Phase 2 Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis Completed
Phase 2 Trial of Ibudilast for Methamphetamine Dependence Completed
Phase 2 Ibudilast and Withdrawal-Related Dysphoria Completed
Phase 2 Ibudilast for the Treatment of Alcohol Use Disorder Completed
Phase 2 A Biomarker Study to Evaluate MN-166 in Subjects With Amyotrophic Literal Sclerosis (ALS) Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.